These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10720911)

  • 1. Isolated ciclosporin-associated arteriopathy does not deteriorate residual renal function in patients with kidney transplantation.
    Matsugami K; Nitta K; Horita S; Honda K; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Nephron; 2000 Mar; 84(3):295-6. PubMed ID: 10720911
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cyclosporin A upon the function of ischemically damaged renal autografts in the dog.
    Homan WP; French ME; Morris PJ
    Transplantation; 1980 Sep; 30(3):228-30. PubMed ID: 14582182
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal artery thromboembolism and immunosuppressive therapy.
    Kronenberg F; Lhotta K; Konigsrainer A; Konig P
    Nephron; 1996; 72(1):101. PubMed ID: 8903871
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine-associated renal arteriopathy.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):151-7. PubMed ID: 3515683
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
    Gossmann J; Radounikli A; Bernemann A; Schellinski O; Raab HP; Bickeböller R; Scheuermann EH
    Kidney Blood Press Res; 2001; 24(2):111-5. PubMed ID: 11435743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
    Mück W; Mai I; Fritsche L; Ochmann K; Rohde G; Unger S; Johne A; Bauer S; Budde K; Roots I; Neumayer HH; Kuhlmann J
    Clin Pharmacol Ther; 1999 Mar; 65(3):251-61. PubMed ID: 10096257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporine on serum lipoprotein(a) levels in renal transplant recipients.
    Sentí M; Puig JM; Lloveras J; Aubó C; Mir M; Barbosa F; Oliveras A; Masramón J
    Transplant Proc; 1997 Aug; 29(5):2404-5. PubMed ID: 9270782
    [No Abstract]   [Full Text] [Related]  

  • 8. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
    Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
    PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of erythrocyte membrane fluidity in cyclosporine-treated renal transplant patients.
    Vareesangthip K; Nimmannit S; Chuawattana D; Mingkam S; Hanlakorn P; Ong-Aj-Yooth L
    Transplant Proc; 2001; 33(1-2):1198-200. PubMed ID: 11267256
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathology of renal allograft].
    Morozumi K; Kodera K; Takeda A
    Rinsho Byori; 1991 Jul; Suppl 90():82-101. PubMed ID: 1920858
    [No Abstract]   [Full Text] [Related]  

  • 11. Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index.
    Grabczewska Z; Obońska K; Adamowicz A; Kasprzak M; Włodarczyk Z; Kubica J
    Transplant Proc; 2013 May; 45(4):1567-70. PubMed ID: 23726621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ciclosporin on whole blood chemiluminescence of renal transplant patients.
    Chen SY; Liu ST; Hou LB; Chen ZL
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):372-5. PubMed ID: 10375788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantation.
    Sugiyama K; Isogai K; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Saito N; Hirano T
    J Clin Pharm Ther; 2009 Oct; 34(5):539-45. PubMed ID: 19744009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment.
    Zehngawa W
    Eur J Clin Pharmacol; 2005 Jun; 61(4):317. PubMed ID: 15891875
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of different dosages of cyclosporine A on the semen parameters of renal transplant patients].
    Xu LG; Xu HM; Zhang JR; Song QZ; Qi XP; Wang XH
    Zhonghua Nan Ke Xue; 2003 Dec; 9(9):679-80, 683. PubMed ID: 14727357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation.
    Shihab FS; Bennett WM; Andoh TF
    Am J Nephrol; 2010; 31(2):134-40. PubMed ID: 19923799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation.
    Kurata Y; Kuzuya T; Miwa Y; Iwasaki K; Haneda M; Amioka K; Yamada K; Watarai Y; Katayama A; Uchida K; Kobayashi T
    Int Immunopharmacol; 2014 Oct; 22(2):384-91. PubMed ID: 25073119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
    Asano T; Murai M; Nakamura H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chemical immunosuppression in baboon allotransplantation: histopathological observations.
    Weber HW; Brede HD; van Zyl JJ; Schoonees R; Groenewald JH; van Zyl JA; de Klerk JN; van Heerden PD; Retief CP
    S Afr Med J; 1968 Aug; ():Suppl:37-41. PubMed ID: 4971039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.